Moderna cancer vaccine with Merck Keytruda reduces the spread of skin cancer
Moderna’s cancer vaccine, used in combination with Merck’s Keytruda, reduced the risk of melanoma spreading to other parts of the body or death by 65% compared to Keytruda alone. According to the American Cancer Society, melanoma accounts for the vast majority of skin cancer deaths. The FDA has given Moderna and Merck breakthrough therapy status … Read more